Browse > Article
http://dx.doi.org/10.3857/jkstro.2008.26.4.222

Perineal Skin Toxicity according to Irradiation Technique in Radiotherapy of Anal Cancer  

You, Sei-Hwan (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System)
Seong, Jin-Sil (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System)
Koom, Woong-Sub (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System)
Publication Information
Radiation Oncology Journal / v.26, no.4, 2008 , pp. 222-228 More about this Journal
Abstract
Purpose: Various treatment techniques have been attempted for the radiotherapy of anal cancer because of acute side effects such as perineal skin reactions. This study was performed to investigate an optimal radiotherapy technique in anal cancer. Materials and Methods: The study subjects included 35 patients who underwent definitive concurrent chemoradiotherapy for anal cancer in Yonsei Cancer Center between 1990 and 2007. The patients' clinical data, including irradiation technique, were reviewed retrospectively. The primary lesion, regional lymph nodes, and both inguinal lymph nodes were irradiated by $41.4{\sim}45\;Gy$ with a conventional schedule, followed by a boost does to the primary lesion or metastatic lymph nodes. The radiotherapy technique was classified into four categories according to the irradiation field and number of portals. In turn, acute skin reactions associated with the treatment interruption period were investigated according to each of the four techniques. Results: 28 patients (80.0%) had grade 2 radiation dermatitis or greater, whereas 10 patients (28.6%) had grade 3 radiation dermatitis or greater during radiotherapy. Radiation dermatitis and the treatment interruption period were relatively lower in patients belonging to the posterior-right-left 3 x-ray field with inguinal electron boost and in patients belonging to electron thunderbird techniques. The interruption periods were $8.2{\pm}10.2$ and $5.7{\pm}7.7$ for the two technique groups, respectively. Twenty-seven patients (77.1%) went into complete remission at 1 month after radiotherapy and the overall 5 year survival rates were 67.7%. Conclusion: Field size and beam arrangement can affect patients' compliance in anal cancer radiotherapy, whereas a small x-ray field for the perineum seems to be helpful by decreasing severe radiation dermatitis.
Keywords
Anal cancer; Radiotherapy; Skin reaction;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Chung WK, Kim SK, Lee CG, Seong J, Kim GE. Concurrent chemoradiotherapy results in patients with anal cancer. J Korean Soc Ther Radiol 1994;12:99-107
2 Vuong T, Franco E, Lehnert S, et al. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys 2004;59:809-814   DOI   ScienceOn
3 Moran M, Lund MW, Ahmad M, Trumpore HS, Haffty B, Nath R. Improved treatment of pelvis and inguinal nodes using modified segmental boost technique: dosimetric evaluation. Int J Radiat Oncol Biol Phys 2004;59:1523-1530   DOI   ScienceOn
4 Gilroy JS, Amdur RJ, Louis DA, Li JG, Mendenhall WM. Irradiation the groin nodes without breaking a leg: a comparison of techniques for groin node irradiation. Med Dosim 2004; 29:258-264   DOI   ScienceOn
5 Charnley N, Choudhury A, Chesser P, Cooper RA, Sebag-Montefiore D. Effective treatment of anal canal in the elderly with low-dose chemotherapy. Br J Cancer 2005;92:1221-1225   DOI   ScienceOn
6 Wong S, Gibbs P, Chao M, et al. Carcinoma of the anal canal: a local experience and review of the literature. ANZ J Surg 2004;74:541-546   DOI   ScienceOn
7 Svensson C, Goldman S, Friberg B, Glimelius B. Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1998;41:863-867   DOI   PUBMED   ScienceOn
8 Chie EK, Ha SW, Park JG, Bang YJ, Heo DS, Kim NK. Treatment results in anal cancer: non-operative treatment versus operative treatment. J Korean Soc Ther Radiol 2002;20: 62-67
9 Nigro N, Vaitkevicius V, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;15:354-356
10 Chie EK, Wu HG, Heo DS, Bang YJ, Kim NK, Ha SW. Neoadjuvant chemotherapy followed by radiotherapy in epidermoid carcinoma of anus. Tumori 2004;90:299-302   DOI   PUBMED
11 John M, Pajak T, Flam MS, et al. Dose acceleration in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Int J Radiat Oncol Biol Phys 1995;32(Suppl.):157
12 Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, Delaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997;39:651-657   DOI   ScienceOn
13 Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15: 2040-2049   DOI
14 Vuong T, Kopek N, Ducruet T, et al. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1394-1400   DOI   ScienceOn
15 Grigsby PW, Roberts HL, Perez CA. Femoral neck fracture following groin irradiation. Int J Radiat Oncol Biol Phys 1995; 32:63-67   DOI   ScienceOn
16 Graf R, Wust P, Hildebrandt B, et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003;65:14-22   DOI   ScienceOn
17 Melcher AA, Sebag-Montefiore D. Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost. Br J Cancer 2003;88:1352-1357   DOI   ScienceOn
18 Mitchell SE, Mendenhall WM, Zlotecki RA, Carroll RR. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2001;49:1007-1013   DOI   ScienceOn
19 Gerard JP, Chapet O, Samiei F, et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal. Cancer 2001;92:77-84   DOI   ScienceOn
20 Weber DC, Kurtz JM, Allal AS. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2001;50:675-680   DOI   ScienceOn
21 Ma L, Chang W, Lau-Chin M, Tate EM, Boyer AL. Using static MLC fields to replace partial transmission cerrobend blocks in treatment planning of rectal carcinoma cases. Med Dosim 1998;23:264-266   DOI   ScienceOn
22 John M, Pajak T, Kreig R, Pinover WH, Myerson R. Dose escalation without split-course chemoradiation for anal cancer: results of a phase II RTOG study. Int J Radiat Oncol Biol Phys 1997;39(2 Suppl. 1):203
23 Vuong T, Devic S, Belliveau P, Muanza T, Hegyi G. Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study. Int J Radiat Oncol Biol Phys 2003;56:823-831   DOI   ScienceOn
24 Devic S, Hegye G, Vuong T, Muanza T, Podgorsak EB. Comparative skin dose measurement in the treatment of anal canal canceer: conventional versus conformal therapy. Med Phys 2004;31:1316-1321   DOI   ScienceOn
25 Myerson RJ, Kong F, Birnbaum EH, et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 2001; 61:15-22   DOI   ScienceOn